The Blue Cross Blue Shield Association's analysis published last month is a watershed moment for UK insurance firms. Hospitals deployed AI tools to submit claims, and the result was $942 million in additional healthcare spending over two years, driven by a sharp spike in complex diagnoses that didn't match actual clinical care. For mid-market UK insurers, this should trigger immediate alarm. Under FCA Consumer Duty PS22/9 and PRA SS1/23, firms must be able to demonstrate that AI systems serving customers do not create hidden risk. A system that inflates claim severity—whether intentionally or through poor training—violates both principles and exposes firms to enforcement action. This isn't theoretical. The ICO and FCA are actively investigating AI governance gaps in financial services. An insurer deploying claims AI without proper audit trails and outcome monitoring is already non-compliant.

This story reveals a pattern we're seeing across regulated sectors: firms treating AI as a drop-in replacement for manual work rather than a governance layer that demands scrutiny. The insurance industry adopted AI claims tools with the same assumption that worked with optical character recognition in the 1990s—that automation simply speeds up what humans already do reliably. That assumption is broken. Modern LLMs and document extraction models are probabilistic. They make errors, they hallucinate, and when deployed against financial incentives (hospitals get paid more for complex diagnoses), they can be gamed. We're not yet seeing UK firms at Blue Cross's scale report similar findings, but that's because most haven't implemented systematic outcome monitoring. The EU AI Act, which will influence UK regulatory thinking, requires high-risk AI systems to have post-deployment surveillance. We're entering an era where 'we didn't know the AI was doing this' is not a defense.

Trovix's view is direct: claims processing AI without governance is worse than no AI at all. It's faster fraud. Tools like Luminance and Harvey excel at document review and legal reasoning where the output is human-verified before use. But claims processing is different—it's high-volume, high-stakes, and feeds directly into financial decisions and patient records. A system must not just extract data accurately; it must flag anomalies, show its reasoning, and create an audit trail that satisfies FCA Consumer Duty requirements. This means Trovix Audit isn't optional—it's foundational. You need continuous monitoring of AI outputs against historical baselines, automated detection of claim severity drift, and explainability that survives regulatory interrogation. Microsoft Copilot and generic LLM wrappers give you speed. They don't give you defensibility. Trovix Sift is built around a different premise: extract documents with confidence scoring, flag uncertainty, surface what the model doesn't understand. That's the difference between a tool and a compliant system.

If you're a mid-market insurer, health insurer, or financial services firm using AI for claims, underwriting, or any high-volume decision-making right now, you need three things this month: (1) an inventory of which AI systems touch claims, underwriting, or fraud decisions; (2) a baseline measure of output quality—claim approval rates, claim severity distribution, approval time—from the 12 months before AI deployment; (3) a plan to audit every AI system touching regulated decisions against that baseline, looking for drift. Don't wait for an FCA probe. The firms that survive the next regulatory cycle will be those that can show they knew what their AI was doing and caught problems before regulators did. This is not about being anti-AI. It's about being competent enough to implement it safely. Blue Cross's finding should be read not as a warning against AI, but as proof that governance is the real product.

Source: TechCrunch